BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18498638)

  • 1. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's.
    Zhao Y; Kuo TC; Weir S; Kramer MS; Ash AS
    BMC Health Serv Res; 2008 May; 8():108. PubMed ID: 18498638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of comorbidity on costs for patients with Alzheimer disease.
    Kuo TC; Zhao Y; Weir S; Kramer MS; Ash AS
    Med Care; 2008 Aug; 46(8):839-46. PubMed ID: 18665064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
    Fillit H; Hill JW; Futterman R
    Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
    Qureshi ZP; Thiel E; Nelson J; Khandker R
    J Alzheimers Dis; 2021; 83(4):1679-1690. PubMed ID: 34420974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
    Suehs BT; Davis CD; Alvir J; van Amerongen D; Pharmd NC; Joshi AV; Faison WE; Shah SN
    Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):384-92. PubMed ID: 23687180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and health care resource utilization among Medicare beneficiaries diagnosed with chronic lymphocytic leukemia.
    Lee TY; Johnson A; Cooke CE; Yared JA; Summers A; Yang K; Liu S; Tang B; Onukwugha E
    J Manag Care Spec Pharm; 2024 May; 30(5):430-440. PubMed ID: 38701030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The direct health care cost to Medicare of Down syndrome dementia as compared with Alzheimer's disease among 2015 Californian beneficiaries.
    Bayen E; Yaffe K; Cleret de Langavant L; Chen Y; Possin KL
    Ann Phys Rehabil Med; 2021 Jan; 64(1):101430. PubMed ID: 32853759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
    Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET
    Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the economic burden of Alzheimer's disease patients first diagnosed by specialists.
    Kirson NY; Desai U; Ristovska L; Cummings AK; Birnbaum HG; Ye W; Andrews JS; Ball D; Kahle-Wrobleski K
    BMC Geriatr; 2016 Jul; 16():138. PubMed ID: 27400711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Household members of persons with Alzheimer's disease: health conditions, healthcare resource use, and healthcare costs.
    Suehs BT; Shah SN; Davis CD; Alvir J; Faison WE; Patel NC; van Amerongen D; Bobula J
    J Am Geriatr Soc; 2014 Mar; 62(3):435-41. PubMed ID: 24576203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.
    Geldmacher DS; Kirson NY; Birnbaum HG; Eapen S; Kantor E; Cummings AK; Joish VN
    Appl Health Econ Health Policy; 2013 Aug; 11(4):407-13. PubMed ID: 23700254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Care Resource Utilization and Costs for Patients with Tardive Dyskinesia.
    Carroll B; Irwin DE
    J Manag Care Spec Pharm; 2019 Jul; 25(7):810-816. PubMed ID: 31232207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare utilization and costs in managed care patients with Alzheimer's disease during the last few years of life.
    McCormick WC; Hardy J; Kukull WA; Bowen JD; Teri L; Zitzer S; Larson EB
    J Am Geriatr Soc; 2001 Sep; 49(9):1156-60. PubMed ID: 11559373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
    Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
    Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.